Literature DB >> 21548712

ReGeneraTing agents matrix therapy regenerates a functional root attachment in hamsters with periodontitis.

Corinne Lallam-Laroye1, Brigitte Baroukh, Philippe Doucet, Denis Barritault, Jean-Louis Saffar, Marie-Laure Colombier.   

Abstract

Matrix-based therapy restoring the cell microenvironment is a new approach in regenerative medicine successfully treating human chronic pathologies by using a heparan sulfate mimetic (ReGeneraTing agents [RGTA]). Periodontitis are inflammatory diseases destroying the tooth-supporting tissues with no satisfactory therapy. We studied in vivo RGTA ability to fully restore the tooth-supporting tissues. After periodontitis induction, hamsters were treated with RGTA (1.5 mg kg(-1) w(-1)) or saline. Bone loss was evaluated and immunohistochemical labeling of molecules expressed during cementum development was performed. RGTA treatment restored alveolar bone and the attachment apparatus where fibers were inserted in acellular decorin-negative cementum. RGTA treatment increased the epithelial rests of Malassez, previously depleted by periodontitis. Bone morphogenetic protein (BMP) expressions were compartmentalized: BMP-3 was strongly expressed by epithelial rests of Malassez; BMP-7 was expressed by cells lying on the cementum and BMP-2 by osteoprogenitors around bone formation sites but not at the root-bone interface. Cells near the cementum and bone expressed the ALK2 receptor. This is the first evidence that reconstructing the extracellular matrix scaffold with a heparan sulfate mimetic regenerated the root interface despite the persistence of the bacteria responsible for the disease The improved cellular microenvironment led to the sequential recruitment of cell populations involved in attachment apparatus regeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548712     DOI: 10.1089/ten.TEA.2010.0696

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  5 in total

1.  Minimal intervention dentistry II: part 2. Management of caries and periodontal risks in general dental practice.

Authors:  C Lallam; F Decup
Journal:  Br Dent J       Date:  2014-02       Impact factor: 1.626

2.  Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.

Authors:  Renata Cimões; Leógenes M Santiago; Arnaldo de França Caldas Júnior; Bruna de Carvalho Farias Vajgel; Jeniffer Perussolo; Nikolaos Donos
Journal:  Clin Oral Investig       Date:  2021-10-13       Impact factor: 3.606

Review 3.  RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients.

Authors:  Denis Barritault; Marie Gilbert-Sirieix; Kim Lee Rice; Fernando Siñeriz; Dulce Papy-Garcia; Christophe Baudouin; Pascal Desgranges; Gilbert Zakine; Jean-Louis Saffar; Johan van Neck
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

4.  In silico analyses of heparin binding proteins expression in human periodontal tissues.

Authors:  Bernadette Lackey; Quentin M Nunes; Susan M Higham; David G Fernig; Sabeel P Valappil
Journal:  BMC Res Notes       Date:  2016-01-28

5.  Periodontal reconstruction by heparan sulfate mimetic-based matrix therapy in Porphyromonas gingivalis-infected mice.

Authors:  Benjamin R Coyac; Laurent Detzen; Philippe Doucet; Brigitte Baroukh; Annie Llorens; Martine Bonnaure-Mallet; Marjolaine Gosset; Denis Barritault; Marie-Laure Colombier; Jean-Louis Saffar
Journal:  Heliyon       Date:  2018-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.